New hope for hepatitis b: Real-World trial of pradefovir underway
Disease control
Ongoing
This study is testing a drug called pradefovir mesylate in 400 adults with chronic hepatitis B. The goal is to see how well it lowers the virus and how safe it is in everyday medical practice, not just in a strict research setting. Participants are being followed for up to 65 wee…
Sponsor: Juan Li • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC